News
IOTOX Algorithm app now available in the Apple app store
The Internal Medicine division has launched the IOTOX Algorithm App, a new clinical tool designed to support oncology and internal medicine providers who manage immune checkpoint inhibitor–related toxicities.
Built on UT MD Anderson’s extensive experience with immune‑related adverse events, the app delivers evidence‑based, organ‑specific algorithms that offer clear, step‑by‑step guidance at the point of care.
The project represents a collaborative effort across the institution, translating years of clinical expertise into a mobile platform that strengthens real‑time decision‑making for faculty and trainees alike.
By centralizing best practices and simplifying access to trusted guidance, the app aims to improve confidence, consistency, and safety in managing ICI toxicities.
This rollout will broaden access across the department and further advance efforts to enhance patient care through innovation in education and clinical practice.
The iOS version is now available in the Apple app store here; the Android version will be released in the near future.
2025 Research Retreat resounding success
On May 15–16, 2025, the Division of Internal Medicine hosted its annual Research Retreat, bringing together a record 249 participants in person and virtually to showcase innovative research and collaboration.
The retreat opened with a poster session featuring work from students, trainees, and fellows across basic science, clinical research, and quality improvement.
Attendees engaged in lively discussion while judges evaluated posters for originality, rigor, clarity, and impact, recognizing outstanding contributions in each category.
The second day featured a keynote address by Michael Irwin, MD, of the David Geffen School of Medicine at UCLA, titled “Insomnia and Inflammation Conspire to Heighten Depression Risk: Implications for Treatment and Prevention of Depression in Cancer Survivorship.”
The program concluded with presentations from Cyrus Scholar Award finalists, with awards presented in Basic Science and Clinical Research.
2025 Cyrus Scholar Award Winners
- Basic Science: Anand Singh, Ph.D., Symptom Research
“Understanding Pediatric Chemotherapy Treatment–Induced Long‑Term Neurological Deficits”
- Clinical Research: Sarah Hamidi, M.D., Endocrine Neoplasia
“Real‑World Experience with Lenvatinib Plus Pembrolizumab in Metastatic BRAF Wild‑Type Anaplastic Thyroid Carcinoma”
2024 IOTOX Symposium merges clinical education and research
On November 6–7, 2024 the Divisions of Internal Medicine and Cancer Medicine hosted the IOTOX Symposium at the new TMC3 Collaborative Building, welcoming more than 200 participants both in person and online.
The symposium combined the IOTOX Clinical Education Symposium and the IOTOX Research Retreat into one event, creating space for clinicians and researchers to learn from each other and share ideas.
With 26 internal and external speakers, the program highlighted new research and practical updates on the care and management of immunotherapy‑related toxicities.
The first day focused on colitis, with experts from clinical, translational, and basic science backgrounds leading presentations and lively discussion.
On day two, speakers explored both preclinical and clinical research approaches, comparing what works, what doesn’t, and where collaboration can move the field forward.Keynote speakers included:
- Padmanee Sharma, MD, PhD, of MD Anderson,
- Pauline Funchain, MD, of Stanford University School of Medicine,
Bringing the research and clinical programs together helped spark meaningful conversation across disciplines and increased engagement throughout the symposium.
The format allowed participants to connect cutting‑edge research with real‑world patient care.Organizers hope to continue growing the event by welcoming even more clinicians, advanced practice providers, and nurses in the future.
Through collaboration and shared learning, the IOTOX Symposium aims to turn research insights into better care and outcomes for patients.